Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was ...

Could the same medication that causes people to lose weight hold the key to reducing drinking? In a new paper at the European ...

Pharma major Biocon says its businesses are at a promising inflection point, with strong momentum expected to continue.

Kiran Mazumdar-Shaw discusses the impact of US drug price reduction efforts on Indian pharma, Biocon's US expansion, strong ...

The biosimilars business accounted for 58% of Biocon's overall revenue in FY25. Biocon Biologics had said it would likely ...

Medications like semaglutide and liraglutide may help to reduce the risk of heart attacks, strokes, and other major adverse ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...

The drugs help severely obese children to lose weight on top of the diet and lifestyle plan they are already following.

Giving obese children weight-loss jabs is effective and helps prevent battles around mealtimes, researchers say. Experts at ...